{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2025:HVT4OPWCPW27MIJXSUUZ44BPSR","short_pith_number":"pith:HVT4OPWC","schema_version":"1.0","canonical_sha256":"3d67c73ec27db5f6213795299e702f9469a1808540efb79f0ca054977b184d27","source":{"kind":"arxiv","id":"2502.09527","version":1},"attestation_state":"computed","paper":{"title":"Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization","license":"http://creativecommons.org/licenses/by-sa/4.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Frank Miller, Magnus Ytterstad, Stig Johan Wiklund","submitted_at":"2025-02-13T17:39:28Z","abstract_excerpt":"Many pharmaceutical companies face concerns with the maintenance of desired revenue levels. Sales forecasts for the current portfolio of products and projects may indicate a decline in revenue as the marketed products approach patent expiry. To counteract the potential downturn in revenue, and to establish revenue growth, an in-flow of new projects into the development phases is required. In this article, we devise an approach with which the in-flow of new projects could be optimized, while adhering to the objectives and constraints set on revenue targets, budget limitations and strategic cons"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2502.09527","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-sa/4.0/","primary_cat":"stat.AP","submitted_at":"2025-02-13T17:39:28Z","cross_cats_sorted":[],"title_canon_sha256":"70782792d3002cc133a0a9881e465ff45ace59c4d7dfd989e0d1e2f2589d790c","abstract_canon_sha256":"48819b2dbbd1c67608e49316f46d633884cce39478e422d77e9474180d439ed0"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T10:17:16.958630Z","signature_b64":"hAvq0YcbPq8EI4alRQXdgpjgsgJRVgCqJPGqY7lAsua80zySZjJRzbL8dIXK52rt8CQXD+s82fcZ3dqdBl0wAA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"3d67c73ec27db5f6213795299e702f9469a1808540efb79f0ca054977b184d27","last_reissued_at":"2026-07-05T10:17:16.958153Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T10:17:16.958153Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization","license":"http://creativecommons.org/licenses/by-sa/4.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Frank Miller, Magnus Ytterstad, Stig Johan Wiklund","submitted_at":"2025-02-13T17:39:28Z","abstract_excerpt":"Many pharmaceutical companies face concerns with the maintenance of desired revenue levels. Sales forecasts for the current portfolio of products and projects may indicate a decline in revenue as the marketed products approach patent expiry. To counteract the potential downturn in revenue, and to establish revenue growth, an in-flow of new projects into the development phases is required. In this article, we devise an approach with which the in-flow of new projects could be optimized, while adhering to the objectives and constraints set on revenue targets, budget limitations and strategic cons"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2502.09527","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2502.09527/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2502.09527","created_at":"2026-07-05T10:17:16.958219+00:00"},{"alias_kind":"arxiv_version","alias_value":"2502.09527v1","created_at":"2026-07-05T10:17:16.958219+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2502.09527","created_at":"2026-07-05T10:17:16.958219+00:00"},{"alias_kind":"pith_short_12","alias_value":"HVT4OPWCPW27","created_at":"2026-07-05T10:17:16.958219+00:00"},{"alias_kind":"pith_short_16","alias_value":"HVT4OPWCPW27MIJX","created_at":"2026-07-05T10:17:16.958219+00:00"},{"alias_kind":"pith_short_8","alias_value":"HVT4OPWC","created_at":"2026-07-05T10:17:16.958219+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/HVT4OPWCPW27MIJXSUUZ44BPSR","json":"https://pith.science/pith/HVT4OPWCPW27MIJXSUUZ44BPSR.json","graph_json":"https://pith.science/api/pith-number/HVT4OPWCPW27MIJXSUUZ44BPSR/graph.json","events_json":"https://pith.science/api/pith-number/HVT4OPWCPW27MIJXSUUZ44BPSR/events.json","paper":"https://pith.science/paper/HVT4OPWC"},"agent_actions":{"view_html":"https://pith.science/pith/HVT4OPWCPW27MIJXSUUZ44BPSR","download_json":"https://pith.science/pith/HVT4OPWCPW27MIJXSUUZ44BPSR.json","view_paper":"https://pith.science/paper/HVT4OPWC","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2502.09527&json=true","fetch_graph":"https://pith.science/api/pith-number/HVT4OPWCPW27MIJXSUUZ44BPSR/graph.json","fetch_events":"https://pith.science/api/pith-number/HVT4OPWCPW27MIJXSUUZ44BPSR/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/HVT4OPWCPW27MIJXSUUZ44BPSR/action/timestamp_anchor","attest_storage":"https://pith.science/pith/HVT4OPWCPW27MIJXSUUZ44BPSR/action/storage_attestation","attest_author":"https://pith.science/pith/HVT4OPWCPW27MIJXSUUZ44BPSR/action/author_attestation","sign_citation":"https://pith.science/pith/HVT4OPWCPW27MIJXSUUZ44BPSR/action/citation_signature","submit_replication":"https://pith.science/pith/HVT4OPWCPW27MIJXSUUZ44BPSR/action/replication_record"}},"created_at":"2026-07-05T10:17:16.958219+00:00","updated_at":"2026-07-05T10:17:16.958219+00:00"}